8.2.3: Anti-lymphocyte monoclonal antibodies

Part of chapter 8 Malignant Disease and Immunosuppression, section 8.2 Drugs affecting the immune response

High-level prescribing trends for Anti-lymphocyte monoclonal antibodies (BNF section 8.2.3) across Parkway Medical Centre for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Alemtuzumab (0802030E0)
Rituximab (0802030F0)
Feedback